| 1. |
 |
When was Aderis Pharmaceuticals founded?
|
| 1A. |
|
Aderis was incorporated in Richmond, Virginia on April 22, 1994 as Discovery Therapeutics, Inc. We changed our name to Aderis Pharmaceuticals in January of 2002.
|
 back to top
|
| 2. |
|
Who has Aderis established licensing agreements with?
|
| 2A. |
|
Aderis has entered into licensing agreements with Schwarz Pharma AG, and King R & D (a subsidiary of King Pharmaceuticals).
|
back to top
|
| 3. |
|
What is the most advanced product in Aderis' pipeline?
|
| 3A. |
|
Our most advanced product is Rotigotine CDS (SPM-962), a dopamine agonist formulated as a transdermal patch for the treatment of Parkinson's disease. This product has completed 3 Phase III trials for both early and late stage Parkinson's Disease. Schwarz Pharma plans to submit New Drug Applications to the FDA and the European regulatory authorities in Q3 2004. It is being developed through a licensing agreement with Schwarz Pharma AG.
|
back to top
|
| 4. |
|
What indications does your company focus on?
|
| 4A. |
|
Aderis' product pipeline currently focuses on indications for CNS and cardiovascular conditions. These include: Parkinson's disease, Restless Leg Syndrome, Cardiac Image Stress Testing, Atrial Fibrillation and Wound Healing in Diabetic Foot Ulcers.
|
back to top
|
| 5. |
|
Where is your base of operations?
|
| 5A. |
|
Aderis has approximately 5,250 sq-ft of office space in Hopkinton, Massachusetts to house corporate management and administration. Additionally, Aderis Pharmaceuticals occupies approximately 7,000 sq-ft of laboratory and office space in Richmond, Virginia for its research and development operations.
|
back to top
|
| 6. |
|
Who are the executive officers for Aderis Pharmaceuticals?
|
| 6A. |
|
The executive officers for Aderis Pharmaceuticals are:
- Kenneth L. Rice Jr., M.B.A., J.D., Vice President, CFO, Chief Commercial Officer and Secretary
- William S. Wheeler, M.D., FACC, Vice President and Chief Medical Officer
- Noel J. Cusack, Ph.D., Vice President and Chief Scientific Officer
- James V. Peck, Pharm. D., Vice President of Operations
- Gevork Minaskanian, Ph.D., Vice President of Chemistry
|
back to top
|
| 7. |
|
Who are the board members for Aderis Pharmaceuticals?
|
| 7A. |
|
The Board of Directors for Aderis Pharmaceuticals consists of:
- Darrell Elliott, Sr. Vice President and Managing Director, Private Equity, MDS Capital Corp.
- Wayne I. Roe, Director, Aradigm Corporation, Ista Pharmaceuticals, Inc. and United Therapeutics, Inc.
|
back to top
|
| 8. |
|
Can you provide a brief description of the Company?
|
| 8A. |
|
Aderis Pharmaceuticals blends expertise in biology, pharmacology and synthetic chemistry to develop selectively acting, small molecule therapeutics. Aderis' product candidates are designed to treat the symptoms and side effects associated with CNS, cardiovascular and renal diseases.
|
back to top
|
| 9. |
|
Can you provide a brief description of Aderis' business strategy?
|
| 9A. |
|
Aderis intends to become a leader in the development and commercialization of innovative selectively-acting, small molecule-based therapies for CNS, acute and chronic cardiovascular and renal diseases. We will continue to expand our clinical pipeline by further developing our expertise in synthetic chemistry and pharmacology, in-licensing product candidates from third parties, and acquiring businesses with complementary product candidates or technologies.
|
back to top
|
| 10. |
|
Is Aderis Pharmaceuticals a public or private company?
|
| 10A. |
|
Aderis Pharmaceuticals is a private company. Its key investors are:
Alliance Technology Ventures; The Palladin Group, a New Jersey-based life science investment firm; Schroder Ventures International Life Sciences, International Biotechnology Trust plc of London, Perseus-Soros Biopharmaceutical Fund LP of San Diego, China Development Industrial Bank of Taiwan, MDS Capital Corp. of Toronto, The NeoMed Fund of Norway, Temasek Capital of Singapore, Singapore BioInnovations of Singapore, and Sanderling BioMedical Ventures of Menlo Park, California.
|
back to top
|
